In brief
- The Oregon Health Authority (OHA) has withdrawn its proposal to double licensing fees for its legal psilocybin program.
- The plan, introduced in July, would have raised manufacturer and service center license fees from $10,000 to $20,000, and doubled facilitator licenses from $2,000 to $4,000.
- The agency will not file final administrative rules; the debate over how to fund the program now moves to the 2027 legislative session.
The Oregon Health Authority (OHA) has announced it will not move forward with the fee hike it proposed in July for its state psilocybin program, the first regulated legal access framework in the United States. The decision, communicated on September 22 to license holders, comes after months of industry pushback.
A hike that threatened to hollow out the program
The original plan would have doubled the annual licensing fees for manufacturers and service centers from $10,000 to $20,000, raised facilitator licenses from $2,000 to $4,000, and octupled worker permits from $25 to $200. It also would have eliminated the 50% fee reduction available to nonprofits, veterans, and low-income individuals. The program receives no public funding and is sustained entirely through fees, yet of the 39 service centers licensed so far, roughly half have already surrendered their licenses or allowed them to lapse.
What the agency says
According to the OHA statement, the decision reflects feedback gathered through the Oregon Psilocybin Advisory Board, rulemaking advisory committees, and the public comment period: the agency will not file permanent administrative rules or adopt the proposed fee increases. Sam Chapman of the Center for Psychedelic Policy summarized the situation to Marijuana Moment: the program is working, but the fee structure was not. His organization is preparing an independent economic analysis ahead of the 2027 legislative session.
What it means
In 2020, Oregon voters approved supervised psilocybin access via ballot initiative, and since 2023 the state has operated the nation’s first program issuing licenses to facilitators, manufacturers, service centers, and testing labs without requiring a medical diagnosis—a pioneer model for regulated psilocybin access. While the agency’s reversal offers immediate relief, it leaves the underlying fiscal dilemma unresolved: how to fund a program that relies entirely on fees when a significant portion of licensed facilities have already shut their doors. The 2027 legislative session will be the next opportunity to explore adjustments that keep the program solvent without burdening an emerging, fragile industry with unsustainable costs.
Source
- Marijuana Moment. Oregon Officials Drop Effort To Hike Psilocybin Business Licensing Fees. Marijuana Moment, September 22, 2026.
Educational content written from a harm reduction perspective and with respect for individual freedom. It is not a substitute for advice from a healthcare professional and is not intended to encourage or condemn any drug use.
